Predicting progression to Alzheimer's disease dementia using cognitive measures
Authors:
Open Access
- 7 February 2024
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 39 (2) , e6067
Abstract
Objectives: It is important to determine if cognitive measures identified as being prognostic in dementia research cohorts also have utility in memory clinics. We aimed to identify measures with the greatest power to predict future Alzheimer's disease (AD) dementia in a clinical setting where expensive biomarkers are not widely available.Methods: This study utilized routine Memory Clinic data collected over 18 years. From 2214 patients assessed in the clinic, we selected 328 patients with an initial diagnosis of subjective cognitive decline or mild cognitive impairment. We compared two types of statistical model for the prediction of AD dementia. The first model included baseline cognitive test scores only, while the second model also included change scores between baseline and the first follow‐up.Results: Baseline scores on tests of global cognitive function (Mini‐mental state examination and Cambridge Cognitive Examination‐Revised), verbal episodic memory and psychomotor speed were the best predictors of conversion to AD dementia. The inclusion of cognitive change scores over 1 year of follow‐up improved predictive accuracy versus baseline scores alone.Conclusions: We found that the best cognitive predictors of AD dementia in a clinical setting were similar to those previously identified using research cohorts. Taking change in cognitive function into account enabled the onset of AD dementia to be predicted with greater accuracy.Keywords
This publication has 23 references indexed in Scilit:
- Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysisActa Psychiatrica Scandinavica, 2014
- The Shape Trail Test: Application of a New Variant of the Trail Making TestPLOS ONE, 2013
- Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer's Disease Neuroimaging InitiativeArchives of General Psychiatry, 2011
- Mild Cognitive Impairment as a Clinical Entity and Treatment TargetArchives of Neurology, 2005
- Equivalence of the Color Trails Test and Trail Making Test in Nonnative English-SpeakersArchives of Clinical Neuropsychology, 2000
- The development of a valid and reliable scale for rating anxiety in dementia (RAID)Aging & Mental Health, 1999
- 9/Geriatric Depression Scale (GDS)Clinical Gerontologist, 1986
- A new rating scale for Alzheimer's diseaseAmerican Journal of Psychiatry, 1984
- Evaluating the yield of medical testsJAMA, 1982
- Validity of the Trail Making Test as an Indicator of Organic Brain DamagePerceptual and Motor Skills, 1958